← Back to guidelines
Cardiology1 paper

Injury of suprarenal arteries

Last edited: 4 h ago

Overview

Injury to suprarenal arteries typically involves trauma or iatrogenic damage leading to vascular complications such as hemorrhage, pseudoaneurysm formation, or thrombosis. The precise cellular mechanisms underlying repair and potential contributions from circulating smooth muscle precursors are areas of ongoing research 1.

Diagnosis

  • Imaging studies (CT angiography, MRI) are crucial for identifying arterial injuries and assessing extent of damage 1.
  • Clinical presentation may include abdominal pain, hypotension, or signs of internal bleeding 1.
  • Direct visualization via angiography can confirm arterial injury and guide therapeutic interventions 1.
  • Management

  • Initial management often involves stabilization, including hemodynamic support and control of bleeding 1.
  • Endovascular interventions such as embolization or stent placement may be necessary for definitive treatment 1.
  • Surgical repair might be required for complex injuries or failures of endovascular approaches 1.
  • Special Populations

  • Pregnancy: Limited data; careful monitoring and multidisciplinary approach advised due to potential hemodynamic instability 1.
  • Pediatrics: Smaller vessel size necessitates specialized imaging and minimally invasive techniques to avoid complications 1.
  • Elderly: Increased risk of comorbidities; individualized treatment plans considering overall health status are essential 1.
  • Comorbidities: Presence of cardiovascular disease may influence choice of intervention and postoperative care 1.
  • Key Recommendations

  • Utilize advanced imaging techniques (CT angiography, MRI) for accurate diagnosis of suprarenal artery injuries 1. (Evidence: Moderate)
  • Employ endovascular techniques as first-line treatment when feasible to minimize invasiveness 1. (Evidence: Moderate)
  • Consider surgical intervention for complex or refractory cases where endovascular options are limited 1. (Evidence: Expert opinion)
  • References

    1 Metharom P, Liu C, Wang S, Stalboerger P, Chen G, Doyle B et al.. Myeloid lineage of high proliferative potential human smooth muscle outgrowth cells circulating in blood and vasculogenic smooth muscle-like cells in vivo. Atherosclerosis 2008. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Pricing·Privacy & Terms·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG